1-(4-Fluorophenyl)-4-oxocyclohexanecarbonitrile, 98.0%, 250mg

2-(6-Aminopurin-9-yl)ethanol, 95.0%, 500g

(S)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 1g

5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, 95.0%, 25g

N-(piperidin-4-yl)cyclopropanesulfonamide hydrochloride, 95.0%, 250mg

5-Amino-2-methyl-2H-tetrazole, 95.0%, 25g

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)25g

2,4,5-Trifluoronitrobenzene>98.0%(GC)5g

TDZD-8, >90%, 5mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-chlorophenyl)propanoic acid, 95.0%, 5g

Ethyl 6-methoxypyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 1g

tert-Butyl 2-(methylsulfonyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 1g

3-METHYL-1H-INDAZOL-6-AMINE, 95%, 25g